<i>Cannabis sativa</i>: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

<i>Cannabis sativa</i>: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC

<i>Cannabis sativa</i> (<i>Cannabis</i>) is one of the world’s most well-known, yet maligned plant species. However, significant recent research is starting to unveil the potential of <i>Cannabis</i> to produce secondary compounds that may offer a suite of medical...

Full description

Bibliographic Details
Main Authors: Jackson M. J. Oultram, Joseph L. Pegler, Timothy A. Bowser, Luke J. Ney, Andrew L. Eamens, Christopher P. L. Grof
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Biomedicines
Subjects:
<i>Cannabis sativa</i> (<i>Cannabis</i>)
cannabinoids
tetrahydrocannabinol (THC)
cannabidiol (CBD)
cannabinoid receptors (CB<sub>1</sub> and CB<sub>2</sub>)
<i>Papaver somniferum</i> (opium poppy)
Online Access:https://www.mdpi.com/2227-9059/9/3/234

Internet

https://www.mdpi.com/2227-9059/9/3/234

Similar Items